GO
Loading...

Johnson & Johnson

More

  • Amgen's Anemia Drug Showdown Wednesday, 12 Mar 2008 | 4:26 PM ET

    Ahead of the big FDA Advisory Committee meeting tomorrow, Amgen held a quick conference call with some reporters this afternoon. The outside panel of experts will be deciding whether to recommend putting more restrictions on the use of the blockbuster drugs used to fight anemia in cancer patients getting chemo. For Johnson and Johnson and especially Amgen, the stakes are high.

  • Amgen, Johnson & Johnson & The FDA Tuesday, 11 Mar 2008 | 1:23 PM ET

    Shares of biotech giant Amgen fell as low as $43.14 (a new bottom) this morning after the briefing documents for Thursday's Food and Drug Administration Advisory Committee meeting were posted on the agency's website.

  • Big Week For Biotech Monday, 10 Mar 2008 | 6:46 PM ET

    This is a big week for the world's top-two biotechnology companies and their investors. What’s going on and how can you trade it?

  • One Giant Leap for MannKind Monday, 10 Mar 2008 | 5:11 PM ET

    Billionaire Alfred Mann must not have liked watching stock in the company bearing his name fall to another new low today in the wake of Eli Lilly giving up on inhaled insulin.

  • Amgen And Genentech: A Big Biotech Double Play Monday, 10 Mar 2008 | 10:50 AM ET
    AMGEN

    This is a big week for the world's top-two biotechnology companies and their investors. Amgen goes before an FDA Advisory Committee Thursday about the side effects of its bread-and-butter franchise Aranesp.

  • Richest Companies vs. Richest Individuals Thursday, 6 Mar 2008 | 12:34 PM ET

    Forbes just released its annual list of the world's wealthiest individuals, with Warren Buffett climbing to the number one spot.  Here is the list of largest companies by Market Cap on the S&P 500. 

  • Big Pharma: Market Medicine? Monday, 3 Mar 2008 | 4:06 PM ET

    With Warren Buffett nosing around Big Pharma, investors are starting to wonder if drug makers might be the remedy to what ails this market.

  • Drug Money Still A "Healthy Flow" To Democrats Monday, 3 Mar 2008 | 9:29 AM ET

    On the eve of the make-or-break Texas-Ohio primaries for Sen. Hillary Clinton, she remains in first place in at least one "poll." The Center for Responsive Politics has updated its list of top pharmaceuticals/health products-industry money recipients based on the most recent campaign finance reports and the former First Lady edges out Sen. Barack Obama...

  • Rockin' Retirees Friday, 29 Feb 2008 | 11:26 PM ET

    What's the trade as a new breed of retirees begin their Miami migration?

  • Where Investors Can Turn For Shelter From Storm Friday, 29 Feb 2008 | 2:32 PM ET
    Christopher Walls, of Institutional Direct Inc., watches a monitor on the floor of  the New York Stock Exchange, Tuesday, Feb. 27,  2007, in New York. Wall Street fell sharply, joining a global stock decline sparked by growing concerns that the U.S. and Chinese economies are cooling and that U.S. stocks are about to embark on a major correction. (AP Photo/Henny Ray Abrams)

    Stocks are tumbling. Bonds yields are falling faster than Hillary Clinton's poll numbers. And fears are growing that the commodities bubble could burst. What to do?

  • Today's Stock Picks: Coal and Dividend Plays Friday, 29 Feb 2008 | 12:06 PM ET

    The economy's worsening. So's inflation. And the stock market is tanking. What to do? CNBC asked market experts for their best investment advice. Here are some of their picks.

  • Go For the Dividends, Says Strategist Friday, 29 Feb 2008 | 10:40 AM ET

    There's nearly $3.5 trillion dollars waiting to be invested in the markets, according to Frederic Dickson, chief market strategist  of D.A. Davidson.  So what's keeping it out?  And what should investors do in the meantime?

  • Stocks For When You Don't Want Stocks Wednesday, 27 Feb 2008 | 8:01 AM ET

    Harbor Advisory's chief investment officer Jack DeGan has no doubts that these are challenging times.  He's got some tough stocks to ride out the rough weather with.

  • As the democratic presidential candidates prepare to square off on health care issues at tonight's debate in Ohio, a new federal study points to accelerating growth in government spending on Medicare over the next ten years, as baby boomers become eligible for the healthcare entitlement program.

  • Trader Radar - Monday Feb. 25th Monday, 25 Feb 2008 | 1:45 PM ET

    Q: On Fast Money’s trader radar we look at the stock that was lighting up screens across Wall Street. Founded in 1887 in a former wallpaper factory, this company was the first maker of ready to use anti-bacterial surgical dressings. Now the maker of Tylenol, it is the world’s largest health products company. But this company doesn't just cure headaches, a medical journal announced Friday that the company’s Remicade drug is proving effective in the treatment of Crohn’s disease Who is it?

  • Pfizer's CEO Kindler Being Kind To Hillary--Again Monday, 25 Feb 2008 | 1:37 PM ET

    According to The Center for Responsive Politics' web site Pfizer Chairman and CEO Jeff Kindler has opened his wallet again for Sen. Hillary Clinton. You can see his latest "give" here. Twice now within the past year Kindler has given the maximum amount ($2,300) an individual can contribute to a candidate.

  • Coffee, Me And A Not So "Sweet" Splenda? Thursday, 21 Feb 2008 | 8:37 AM ET
    Splenda

    How much coffee can one woman drink? Watch me. I never drank coffee until I started covering the O.J. Simpson trial (come to think of it, I never drank much alcohol before then, either).

  • Boxes of Kraft Macaroni and Cheese are seen Wednesday, April 19, 2006, in Milwaukee. Kraft Foods Inc. releases first-quarter earnings after the bell.  (AP Photo/Morry Gash)

    Warren Buffett's Berkshire Hathaway has accumulated an 8.6% stake in Kraft Foods, totaling over 132 million shares as of the end of the fourth quarter on December 31. That stake was worth $4.3 billion at that time. At today's closing price of $29.31, it's worth about $3.9 billion.  EXPLORE WARREN BUFFETT'S INVESTMENTS WITH OUR NEW BERKSHIRE HATHAWAY PORTFOLIO TRACKER

  • Genentech, JNJ, Pfizer: Big Days Ahead For Pharma Friday, 15 Feb 2008 | 9:41 AM ET

    Taking an extra day off to extend the long weekend before we go into a very busy period. Possibly a week from today (Friday) Genentech could get word from the Food and Drug Administration on its cancer drug Avastin for breast cancer. The agency could approve it, reject it or delay making a decision.

  • There was a mini-rally and spike in volume in shares of good ol' Dendreon this morning and early afternoon. The run-up occured ahead of CEO Dr. Mitchell Gold's presentation at the BIO CEO conference in New York City at 1:15 ET.